Type 2 Diabetes Drugs News

The U.S. Food and Drug Administration (FDA) has received reports linking certain serious and painful skin diseases to Dipeptidyl peptidase (DPP-4) inhibitors, including: Bullous Pemphigoid Erythema multiforme Drug eruption Stevens-Johnson syndrome Eczema Oculomucocutaneous syndrome The onset of these reactions typically occurred within the first three […]

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes patients have been found to cause severe and debilitating joint pain, according to the U.S. Food and Drug Administration (FDA). What are DPP-4 Inhibitors? DPP-4 inhibitors like Januvia (sitagliptin), Onglyza (saxagliptin), Tradjenta (linagliptin), and Nesina (alogliptin) are used, […]